X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Sensi Products unveils new pharma-grade and child-resistant packaging

Content Team by Content Team
2nd May 2019
in Packaging & Logistic, Press Statements
Sensi packaging

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Sensi Products, the licensed cannabis manufacturer of Sensi Chew, has introduced new pharma-grade and child-resistant packaging.

The new California compliant packaging, which features an informational insert to improve the user experience, has been designed for cannabis infused chocolate caramels.

The new packaging and automated manufacturing process will help the company to meet the growing market demand for its cannabis edibles.

Available in more than 240 licensed dispensaries and delivery services across California, Sensi Chews are provided in 90mg pack with 10-9mg individual doses.

The company is providing a family of nine products under three specific categories.

Classic is comprised of Sativa, Indica, Hybrid, while Specialty includes added formulations for insomnia, energy, and sexual enhancement. CBD is comprised of CBD-only, 1:1 CBD to THC, and CBD for Insomnia.

Sensi Products CSMO Lisa Tollner said: “Since its inception Sensi Chew has focused on helping users select a product based on time of day use and will continue to use our ‘Daytime. Nighttime. Anytime’ product segmentation to assist consumers in knowing when to use which chew. All products are color-coded to help users as well as budtenders to easily identify each product.”

Sensi Chew Insomnia is a major cannabis sleep-aid product on the market, said the company.

The company has made an investment in research on sleep, pain, and anxiety, and is planning to launch focused reports on the findings.

Sensi Products CEO Edic Sliva said: “Our goal is to bring Sensi Chew Insomnia to the millions of people who struggle to sleep each night.

“Sensi Chew Insomnia can replace the harmful side-effects of traditional sleep aids to give users a healthy alternative and the deep restful sleep they deserve.”

Sensi Products was established by Edic Sliva and Lisa Tollner in 2013. Edic Sliva is also the founder of Microlux that offers electronics, design, and manufacturing services for medical devices, consumer goods, automotive and military products.

Lisa Tollner established Cintara Corp, which is a full-service brand marketing firm that provides services to firms in high tech, healthcare, consumer goods, and hospitality industries.

 

Previous Post

SGS Implements Veeva Vault Clinical Trial Management System across Global Network

Next Post

Manufacturing growth sees surging demand at CPhI South East Asia

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
CPhI South East Asia

Manufacturing growth sees surging demand at CPhI South East Asia

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In